Bausch Health Companies Inc BHC

Bausch Health Companies Inc. is a global company that develops, manufactures, and markets medical devices, pharmaceuticals, and over-the-counter products. The company focuses on the therapeutic areas of dermatology, eye health, and gastroenterology. Founded in 1959, Bausch Health has its headquarters in Laval, Canada.

Formerly known as Valeant Pharmaceuticals International, Inc., the company changed its name to Bausch Health Companies Inc. in July 2018. The company's segments include Ortho Dermatologics, Salix, Bausch + Lomb, International Rx, and Diversified Products. The company's Ortho Dermatologics segment handles sales of dermatological products in the United States and global sales of Solta medical aesthetic devices. The Salix segment handles sales of gastroenterology products within the United States, while the Bausch + Lomb segment handles sales of vision care and ophthalmology prescription products within the United States. Bausch Health's Diversified Products segment sells pharmaceutical products for neurology and other therapeutic classes, in addition to dentistry and generic products in the United States.

Available on the NYSE, Bausch Health stock is listed under the ticker BHC. The company has manufacturing and marketing operations in more than 90 countries and regions as of December 2021, including in the United States, Canada, Europe, the Middle East, Africa, Asia Pacific, and Latin America.

Explore BHC share price values by adding it to your eToro virtual portfolio.